Plain-English translation of NCT06000956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a herbal medication, to see if it can help reduce pain and improve function in people with active ankylosing spondylitis (a condition that causes inflammation in the spine and joints). About half of the participants will receive the real medication while the other half will receive a placebo (a look-alike tablet with no active ingredient), so researchers can fairly compare how well the medication works.
Ankylosing spondylitis can be painful and limit how much people can move and do in daily life. Researchers want to see if this medication can help reduce pain and inflammation better than placebo, and whether it is safe to use.
You likely qualify if…
You likely don't qualify if…
You will take either or a placebo tablet by mouth daily throughout the study. You will attend regular clinic visits for examinations and follow-up assessments, where doctors will check how you're doing, measure your pain levels, and monitor your blood work and imaging. The study will track whether the medication helps improve your symptoms and whether it is safe.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China